Levitronix Ventricular Assist Devices as a Bridge to Recovery After Profound Biventricular Heart Failure Associated With Pulmonary Aspergillosis

Bryan A. Whitson, Jonathan D'Cunha, Amy C. Knutsen, Andrew J. Boyle, Kenneth Liao

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

A patient with multisystem organ failure and refractory cardiopulmonary shock stemming from Aspergillus pneumonia was treated with 2 Levitronix ventricular assist devices as a bridge-to-recovery. After ventricular assist device placement, the patient recovered myocardial function. The ventricular assist devices were removed on post-implant Day 7, and the patient made a full long-term recovery. Ventricular assist devices should be strongly considered, as bridges to recovery, to support patients with acute myocardial dysfunction associated with sepsis while the underlying infection is treated.

Original languageEnglish (US)
Pages (from-to)345-349
Number of pages5
JournalJournal of Heart and Lung Transplantation
Volume26
Issue number4
DOIs
StatePublished - Apr 1 2007

Fingerprint Dive into the research topics of 'Levitronix Ventricular Assist Devices as a Bridge to Recovery After Profound Biventricular Heart Failure Associated With Pulmonary Aspergillosis'. Together they form a unique fingerprint.

Cite this